\Amhr2tm3(cre)Bhr/\Amhr2+ \Ctnnb1tm1Mmt/\Ctnnb1+ \Ptentm1Hwu/\Ptentm1Hwu
involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ
|
anemia |
J:142150
|
decreased hematocrit |
J:142150
|
extramedullary hematopoiesis |
J:142150
|
increased granulosa cell tumor incidence |
J:149060
|
increased metastatic potential |
J:142150,
J:149060
|
increased ovary tumor incidence |
J:142150
|
increased testis tumor incidence |
J:149060
|
premature death |
J:142150
|
pulmonary embolism |
J:142150
|
seminiferous tubule degeneration |
J:149060
|
\Amhr2tm3(cre)Bhr/\Amhr2+ \Ctnnb1tm1Mmt/\Ctnnb1+ \Ptentm1Hwu/\Ptentm1Hwu
involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6
|
increased granulosa cell tumor incidence |
J:186144
|
increased testis tumor incidence |
J:186144
|
\ApcMin/\ApcMin \Ctnnb1tm4.1Wbm/\Ctnnb1+
involves: 129 * 129P2/OlaHsd * C57BL/6
|
embryonic lethality between implantation and somite formation, complete penetrance |
J:156864
|
\ApcMin/\Apctm1Tno \Ctnnb1tm4.1Wbm/\Ctnnb1+
involves: 129 * 129P2/OlaHsd * 129S4/SvJae * C57BL/6
|
normal
craniofacial phenotype |
J:156864
|
increased hepatocellular carcinoma incidence |
J:156864
|
intestine polyps |
J:156864
|
normal
nervous system phenotype |
J:156864
|
\Apctm1Rak/\Apc+ \Ctnnb1tm1.2Wvv/\Ctnnb1+
involves: 129P2/OlaHsd * C57BL/6J
|
abnormal telencephalon development |
J:185942
|
embryonic lethality, complete penetrance |
J:185942
|
rostral body truncation |
J:185942
|
\Apctm1Rsmi/\Apc+ \Ctnnb1tm1Wvv/\Ctnnb1+ \Tg(Fabp1-cre)1Jig/?
involves: 129P2/OlaHsd * C57BL/6J * FVB/N
|
increased gastrointestinal tumor incidence |
J:185942
|
\Apctm1Tno/\Apctm1Tno \Ctnnb1tm4.1Wbm/\Ctnnb1+
involves: 129 * 129P2/OlaHsd * 129S4/SvJae * C57BL/6
|
decreased tumor incidence |
J:156864
|
\Apctm2Rfo/\Apc+ \Ctnnb1tm1.2Wvv/\Ctnnb1+
involves: 129P2/OlaHsd * C57BL/6J
|
embryonic lethality, complete penetrance |
J:185942
|
rostral body truncation |
J:185942
|
\Axin1tm4Cos/\Axin1tm4Cos \Ctnnb1tm2.1Kem/\Ctnnb1+
involves: 129S1/Sv * 129X1/SvJ * FVB/N
|
abnormal brain morphology |
J:147293
|
abnormal facial morphology |
J:147293
|
abnormal head morphology |
J:147293
|
abnormal nose morphology |
J:147293
|
cleft palate |
J:147293
|
normal
mortality/aging |
J:147293
|
\Bmpr1atm2.1Bhr/\Bmpr1atm2.1Bhr \Ctnnb1tm1Mmt/\Ctnnb1+ \Krt14tm1.1(cre)Wbm/\Krt14+
involves: 129P2/OlaHsd * 129S7/SvEvBrd * 129X1/SvJ
|
decreased tumor-free survival time |
J:199091
|
increased hair follicle number |
J:199091
|
increased salivary gland tumor incidence |
J:199091
|
increased squamous cell carcinoma incidence |
J:199091
|
\Cdkn1atm1Led/\Cdkn1atm1Led \Ctnnb1tm1Mmt/\Ctnnb1tm1Mmt \Tg(Upk2-cre)6Xrw/0
involves: 129S6/SvEvTac * 129X1/SvJ * FVB/N
|
increased urinary bladder carcinoma incidence |
J:234236
|
premature death |
J:234236
|
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp \Ctnnb1tm1Mmt/\Ctnnb1tm1Mmt \Ptentm1Rps/\Ptentm1Rps \Tg(Tyr-cre/ERT2)13Bos/0
involves: 129/Sv * C57BL/6J * FVB * SJL
|
increased melanoma incidence |
J:155731
|
\Col1a1tm2(tetO-CTNNB1*)Hoch/\Col1a1tm2(tetO-CTNNB1*)Hoch \Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
involves: 129S4/SvJae * C57BL/6
|
abnormal crypts of Lieberkuhn morphology |
J:191050
|
abnormal intestinal epithelium morphology |
J:191050
|
abnormal intestinal goblet cell morphology |
J:191050
|
abnormal large intestine crypts of Lieberkuhn morphology |
J:191050
|
abnormal small intestine crypts of Lieberkuhn morphology |
J:191050
|
\Ctnnb1Bfc/\Ctnnb1+ \Dkk1tm1Lmgd/\Dkk1+
either: (involves: 129/Sv * BALB/cCrl * C3H/HeNCrl) or (involves: 129/Sv * BALB/cCrl * C3H/HeNCrl * C57BL/6)
|
abnormal eye morphology |
J:170646
|
abnormal head morphology |
J:170646
|
preweaning lethality, incomplete penetrance |
J:170646
|
\Ctnnb1Bfc/\Ctnnb1+ \Dkk1tm1Lmgd/\Dkk1+ \Lrp6Gw/\Lrp6+
either: (involves: 101/H * 129 * BALB/cCrl * C3H) or (involves: 101/H * 129 * BALB/cCrl * C3H * C57BL/6)
|
abnormal head size |
J:170646
|
caudal body truncation |
J:170646
|
\Ctnnb1Bfc/\Ctnnb1+ \Lrp6Gw/\Lrp6+
either: (involves: 101/H * BALB/cCrl * C3H) or (involves: 101/H * BALB/cCrl * C3H * C57BL/6)
|
abnormal head size |
J:170646
|
\Ctnnb1Bfc/\Ctnnb1Bfc \Dkk1tm1Lmgd/\Dkk1+
either: (involves: 129/Sv * BALB/cCrl * C3H/HeNCrl) or (involves: 129/Sv * BALB/cCrl * C3H/HeNCrl * C57BL/6)
|
abnormal head size |
J:170646
|
\Ctnnb1tm1(Nfkbia)Rsu/\Ctnnb1+
involves: 129P2/OlaHsd * C57BL/6
|
abnormal cervical lymph node morphology |
J:71744
|
abnormal coat appearance |
J:71744
|
abnormal coat/ hair morphology |
J:71744
|
abnormal cornea epithelium morphology |
J:71744
|
abnormal cornea stroma morphology |
J:71744
|
abnormal eye morphology |
J:71744
|
abnormal eyelid margin morphology |
J:71744
|
abnormal foot pad morphology |
J:71744
|
abnormal hair follicle development |
J:71744
|
abnormal hair growth |
J:71744
|
abnormal intestinal goblet cell morphology |
J:71744
|
abnormal macrophage physiology |
J:71744
|
abnormal nitric oxide homeostasis |
J:71744
|
abnormal peripheral lymph node morphology |
J:71744
|
abnormal small intestine morphology |
J:71744
|
abnormal sweat gland morphology |
J:71744
|
abnormal vibrissa follicle morphology |
J:71744
|
absent hair follicles |
J:71744
|
absent Meibomian glands |
J:71744
|
absent peripheral lymph nodes |
J:71744
|
absent Peyer's patches |
J:71744
|
absent popliteal lymph nodes |
J:71744
|
alopecia |
J:71744
|
blindness |
J:71744
|
conjunctivitis |
J:71744
|
deafness |
J:71744
|
decreased body size |
J:71744
|
decreased hair follicle number |
J:71744
|
decreased litter size |
J:71744
|
decreased Peyer's patch number |
J:71744
|
domed cranium |
J:71744
|
dry eyes |
J:71744
|
early eyelid opening |
J:71744
|
gastrointestinal hemorrhage |
J:71744
|
growth retardation of incisors |
J:71744
|
growth retardation of molars |
J:71744
|
Harderian gland atrophy |
J:71744
|
hunched posture |
J:71744
|
impaired balance |
J:71744
|
increased granulocyte number |
J:71744
|
increased hair follicle apoptosis |
J:71744
|
increased hepatocyte apoptosis |
J:71744
|
increased inflammatory response |
J:71744
|
increased leukocyte cell number |
J:71744
|
increased susceptibility to otitis media |
J:71744
|
increased susceptibility to parasitic infection |
J:71744
|
keratoconjunctivitis sicca |
J:71744
|
kinked tail |
J:71744
|
lethargy |
J:71744
|
liver hemorrhage |
J:71744
|
misaligned incisors |
J:71744
|
narrow eye opening |
J:71744
|
premature death |
J:71744
|
prenatal lethality, incomplete penetrance |
J:71744
|
short incisors |
J:71744
|
small axillary lymph nodes |
J:71744
|
small brachial lymph nodes |
J:71744
|
small molars |
J:71744
|
small Peyer's patches |
J:71744
|
sparse vibrissae |
J:71744
|
tremors |
J:71744
|
\Ctnnb1tm1(Nfkbia)Rsu/\Ctnnb1tm1(Nfkbia)Rsu
involves: 129P2/OlaHsd * C57BL/6
|
prenatal lethality, complete penetrance |
J:71744
|
\Ctnnb1tm1.2Wvv/\Ctnnb1+
involves: 129P2/OlaHsd * C57BL/6J
|
increased gastrointestinal tumor incidence |
J:185942
|
increased intestinal adenocarcinoma incidence |
J:185942
|
increased intestinal adenoma incidence |
J:185942
|
\Ctnnb1tm1.2Wvv/\Ctnnb1tm1.2Wvv
involves: 129P2/OlaHsd * C57BL/6J
|
abnormal anterior head development |
J:185942
|
abnormal craniofacial development |
J:185942
|
abnormal cranium morphology |
J:185942
|
abnormal head morphology |
J:185942
|
abnormal mandibular prominence morphology |
J:185942
|
abnormal maxillary prominence morphology |
J:185942
|
abnormal nasal capsule morphology |
J:185942
|
abnormal tongue morphology |
J:185942
|
absent maxilla |
J:185942
|
facial cleft |
J:185942
|
microcephaly |
J:185942
|
perinatal lethality, complete penetrance |
J:185942
|
\Ctnnb1tm1Max/\Ctnnb1+ \Hesx1tm1Icar/\Hesx1tm1Icar
involves: 129P2/OlaHsd * 129S * 129X1/SvJ * C57BL/6
|
abnormal forebrain development |
J:181005
|
anophthalmia |
J:181005
|
microphthalmia |
J:181005
|
small embryonic telencephalon |
J:181005
|
\Ctnnb1tm1Max/\Ctnnb1+ \Hesx1tm1(cre)Jpmb/\Hesx1tm1Icar
involves: 129P2/OlaHsd * 129S * 129X1/SvJ * C57BL/6
|
abnormal forebrain development |
J:181005
|
anophthalmia |
J:181005
|
microphthalmia |
J:181005
|
small embryonic telencephalon |
J:181005
|
\Ctnnb1tm1Max/\Ctnnb1tm2Kem \Hesx1tm1(cre)Jpmb/\Hesx1tm1Icar
involves: 129P2/OlaHsd * 129S * 129X1/SvJ * C57BL/6
|
anophthalmia |
J:181005
|
microphthalmia |
J:181005
|
small embryonic telencephalon |
J:181005
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Tcf7tm1Cle/\Tcf7+
involves: 129P2/OlaHsd * 129X1/SvJ
|
abnormal bone structure |
J:98430
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Trp53tm1Brn/\Trp53+ \Tg(Fabp7-cre,-lacZ)3Gtm/0
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA
|
increased medulloblastoma incidence |
J:186709
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Fgfr3tm4Cxd/\Fgfr3+ \Tg(Upk2-cre)6Xrw/0
involves: 129S6/SvEvTac * 129X1/SvJ * FVB/N
|
abnormal urinary bladder urothelium morphology |
J:174242
|
increased lung tumor incidence |
J:174242
|
normal
neoplasm |
J:174242
|
premature death |
J:174242
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Ptentm1Hwu/\Ptentm1Hwu \Tg(CYP19A1-cre)1Jri/0
involves: 129S4/SvJae * 129X1/SvJ * C57BL/6
|
decreased circulating estradiol level |
J:186144
|
decreased circulating progesterone level |
J:186144
|
decreased granulosa cell apoptosis |
J:186144
|
decreased tumor-free survival time |
J:186144
|
impaired granulosa cell differentiation |
J:186144
|
increased circulating follicle stimulating hormone level |
J:186144
|
increased circulating luteinizing hormone level |
J:186144
|
increased granulosa cell proliferation |
J:186144
|
increased granulosa cell tumor incidence |
J:186144
|
increased ovary tumor incidence |
J:186144
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Ptentm1Hwu/\Ptentm1Hwu \Tg(Upk2-cre)6Xrw/0
involves: 129S4/SvJae * 129X1/SvJ * FVB/N
|
increased urinary bladder carcinoma incidence |
J:164579
|
premature death |
J:164579
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Tg(Wap-cre)11738Mam/0 \Tg(Wap-Hgf)402Mig/0
FVB.Cg-Ctnnb1tm1Mmt Tg(Wap-cre)11738Mam Tg(Wap-Hgf)402Mig
|
abnormal mammary gland growth during lactation |
J:206839
|
abnormal mammary gland morphology |
J:206839
|
increased mammary gland tumor incidence in breeding females |
J:206839
|
increased mammary gland tumor incidence in virgin females |
J:206839
|
mammary gland alveolar hyperplasia |
J:206839
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Krastm4Tyj/\Kras+ \Amhr2tm3(cre)Bhr/\Amhr2+
involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6
|
increased granulosa cell tumor incidence |
J:186144
|
increased testis tumor incidence |
J:186144
|
seminiferous tubule degeneration |
J:186144
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Krastm4Tyj/\Kras+ \Tg(Upk2-cre)6Xrw/0
involves: 129S4/SvJae * 129X1/SvJ * FVB/N
|
increased lung tumor incidence |
J:174242
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Krastm4Tyj/\Kras+ \Tg(CYP19A1-cre)1Jri/0
involves: 129S4/SvJae * 129X1/SvJ * C57BL/6
|
decreased circulating estradiol level |
J:186144
|
decreased circulating progesterone level |
J:186144
|
impaired granulosa cell differentiation |
J:186144
|
increased circulating follicle stimulating hormone level |
J:186144
|
increased circulating luteinizing hormone level |
J:186144
|
increased granulosa cell tumor incidence |
J:186144
|
increased ovary tumor incidence |
J:186144
|
premature death |
J:186144
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+ \Prom1tm1(cre/ERT2)Gilb/\Prom1+
involves: 129S6/SvEvTac * 129X1/SvJ
|
increased intestinal adenocarcinoma incidence |
J:144215
|
premature death |
J:144215
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Cxcr4tm2Yzo/\Cxcr4tm2Yzo \Tg(Wap-cre)11738Mam/0 \Tg(Wap-Hgf)402Mig/0
FVB.Cg-Cxcr4tm2Yzo Ctnnb1tm1Mmt Tg(Wap-cre)11738Mam Tg(Wap-Hgf)402Mig
|
decreased mammary gland tumor incidence in breeding females |
J:206839
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Wnt9btm1.1Amc/\Wnt9btm1.2Amc \Tg(Cdh16-cre)91Igr/0
involves: 129X1/SvJ * ICR
|
kidney cyst |
J:151498
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Krastm1Bbd/\Kras+ \Tg(Pbsn-cre)4Prb/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2
|
increased prostate gland tumor incidence |
J:143034
|
premature death |
J:143034
|
squamous metaplasia of bulbourethral gland |
J:143034
|
squamous metaplasia of urethral gland |
J:143034
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Rspo1tm1Mcch/\Rspo1tm1Mcch \Tg(Nr5a1-cre)5Asc/?
involves: 129/Sv * C57BL/6 * CBA
|
embryonic lethality, incomplete penetrance |
J:133933
|
normal
reproductive system phenotype |
J:133933
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Ppargtm1.1(tTA)Jmgr/\Pparg+ \Tg(tetO-cre)1Jaw/0
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6
|
abnormal osteoclast differentiation |
J:178340
|
abnormal trabecular bone morphology |
J:178340
|
absent bone marrow cell |
J:178340
|
decreased bone marrow cell number |
J:178340
|
decreased bone resorption |
J:178340
|
decreased osteoclast cell number |
J:178340
|
extramedullary hematopoiesis |
J:178340
|
increased bone trabecula number |
J:178340
|
increased bone volume |
J:178340
|
increased compact bone volume |
J:178340
|
increased splenocyte number |
J:178340
|
increased trabecular bone thickness |
J:178340
|
increased trabecular bone volume |
J:178340
|
osteopetrosis |
J:178340
|
normal
skeleton phenotype |
J:178340
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Pik3catm1Gilb/\Pik3ca+ \Trp53tm1Brn/\Trp53+ \Tg(Fabp7-cre,-lacZ)3Gtm/0
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA
|
increased medulloblastoma incidence |
J:186709
|
\Ctnnb1tm1Mmt/\Ctnnb1+ \Igs2tm1(CAG-Met)Zsu/\Igs2+ \Tg(Pbsn-cre)4Prb/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 * FVB/N
|
increased prostate gland adenocarcinoma incidence |
J:284956
|
increased prostate intraepithelial neoplasia incidence |
J:284956
|
\Ctnnb1tm1Mmt/\Ctnnb1tm1Mmt \Gt(ROSA)26Sortm2(Sp8)Lma/\Gt(ROSA)26Sor+ \Tg(Msx2-cre)5Rem/0
involves: 129X1/SvJ * C57BL/6 * CBA
|
normal
limbs/digits/tail phenotype |
J:223057
|
\Ctnnb1tm1Mmt/\Ctnnb1tm1Mmt \Krastm4Tyj/\Kras+ \Tg(Upk2-cre)6Xrw/0
involves: 129S4/SvJae * 129X1/SvJ * FVB/N
|
increased urinary bladder carcinoma incidence |
J:234236
|
premature death |
J:234236
|
\Ctnnb1tm1Mmt/\Ctnnb1tm1Mmt \Ptentm1Hwu/\Ptentm1Hwu \Tg(Upk2-cre)6Xrw/0
involves: 129S4/SvJae * 129X1/SvJ * FVB/N
|
increased urinary bladder carcinoma incidence |
J:164579
|
premature death |
J:164579
|
\Ctnnb1tm1Mmt/\Ctnnb1tm1Mmt \Sp8tm1Smb/\Sp8tm1Smb \Tg(Msx2-cre)5Rem/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
|
normal
limbs/digits/tail phenotype |
J:223057
|
\Ctnnb1tm1Mmt/\Ctnnb1tm1Mmt \Tg(Upk2-cre)6Xrw/0 \Tg(Upk2-HRAS*Q61L)5Xrw/0
involves: 129X1/SvJ * FVB/N
|
hematuria |
J:234236
|
increased urinary bladder carcinoma incidence |
J:234236
|
premature death |
J:234236
|
\Ctnnb1tm1Yy/\Ctnnb1tm1.1Yy \Ptch1tm1Yy/\Ptch1tm1.1Yy \Tg(Col2a1-cre)1Bhr/0
involves: 129S6/SvEvTac * C57BL/6 * SJL
|
abnormal elbow joint morphology |
J:112462
|
abnormal long bone hypertrophic chondrocyte zone |
J:112462
|
abnormal perichondrium morphology |
J:112462
|
arrested osteoblast differentiation |
J:112462
|
normal
craniofacial phenotype |
J:112462
|
decreased bone mineralization |
J:112462
|
delayed endochondral bone ossification |
J:112462
|
fused synovial joints |
J:112462
|
\Ctnnb1tm2(Nfkbia)Rsu/\Ctnnb1+ \Tg(CMV-cre)1Cgn/0
involves: 129P2/OlaHsd * BALB/cJ * C57BL/6
|
abnormal eye morphology |
J:71744
|
abnormal eyelid morphology |
J:71744
|
abnormal hair follicle development |
J:71744
|
abnormal hair growth |
J:71744
|
abnormal incisor morphology |
J:71744
|
abnormal intestinal goblet cell morphology |
J:71744
|
abnormal lymph node morphology |
J:71744
|
abnormal macrophage physiology |
J:71744
|
abnormal molar morphology |
J:71744
|
abnormal Peyer's patch morphology |
J:71744
|
abnormal small intestine morphology |
J:71744
|
absent Meibomian glands |
J:71744
|
alopecia |
J:71744
|
blindness |
J:71744
|
deafness |
J:71744
|
decreased body size |
J:71744
|
decreased litter size |
J:71744
|
domed cranium |
J:71744
|
dry eyes |
J:71744
|
gastrointestinal hemorrhage |
J:71744
|
Harderian gland atrophy |
J:71744
|
hunched posture |
J:71744
|
increased granulocyte number |
J:71744
|
increased hepatocyte apoptosis |
J:71744
|
increased inflammatory response |
J:71744
|
increased leukocyte cell number |
J:71744
|
increased susceptibility to otitis media |
J:71744
|
keratoconjunctivitis sicca |
J:71744
|
kinked tail |
J:71744
|
lethargy |
J:71744
|
liver hemorrhage |
J:71744
|
prenatal lethality, incomplete penetrance |
J:71744
|
sparse hair |
J:71744
|
sparse vibrissae |
J:71744
|
tremors |
J:71744
|
\Ctnnb1tm2(Nfkbia)Rsu/\Ctnnb1+ \Tg(Myh6-cre)2182Mds/0
B6.Cg-Ctnnb1tm2(Nfkbia)Rsu Tg(Myh6-cre)2182Mds
|
decreased response of heart to induced stress |
J:111645
|
\Ctnnb1tm2(Nfkbia)Rsu/\Ctnnb1tm2(Nfkbia)Rsu \Tg(Runx2-icre)1Jtuc/0
involves: 129P2/OlaHsd * FVB/N
|
normal
skeleton phenotype |
J:160669
|
\Ctnnb1tm2.1Kem/\Ctnnb1+ \Otx2tm1(Dkk1)Imat/\Otx2tm1(Dkk1)Imat
involves: 129/Sv * C57BL/6 * CBA
|
abnormal rostral-caudal axis patterning |
J:103272
|
\Ctnnb1tm2.1Kem/\Ctnnb1+ \Sall4Gt(W097E01)Flo/\Sall4+
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6
|
abnormal anterior primitive streak morphology |
J:138922
|
abnormal mesoderm development |
J:138922
|
embryonic growth retardation |
J:138922
|
preweaning lethality, complete penetrance |
J:138922
|
\Ctnnb1tm2Kba/\Ctnnb1tm2Kba
involves: 129S6/SvEvTac * C57BL/6
|
abnormal gastrulation |
J:178971
|
absent mesoderm |
J:178971
|
embryonic lethality between implantation and somite formation, complete penetrance |
J:178971
|
\Ctnnb1tm2Kem/\Ctnnb1+ \Ptentm1Hwu/\Ptentm1Hwu \Tg(Cdh5-cre)7Mlia/0
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c * C57BL/6 * FVB/N
|
abnormal blood vessel morphology |
J:135172
|
abnormal definitive hematopoiesis |
J:135172
|
premature death |
J:135172
|
\Ctnnb1tm2Kem/\Ctnnb1+ \Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/\Gt(ROSA)26Sor+ \Tg(Col2a1-cre)1Bhr/0 \Tg(tetO-Vegfa)90Ala/0
involves: 129 * C57BL/6 * FVB/N * ICR * SJL
|
increased hemangioma incidence |
J:156474
|
normal
skeleton phenotype |
J:156474
|
\Ctnnb1tm2Kem/\Ctnnb1+ \Hesx1tm1(cre)Jpmb/\Hesx1tm1Icar
involves: 129P2/OlaHsd * 129S * 129X1/SvJ * C57BL/6
|
abnormal forebrain development |
J:181005
|
anophthalmia |
J:181005
|
microphthalmia |
J:181005
|
small embryonic telencephalon |
J:181005
|
\Ctnnb1tm2Kem/\Ctnnb1+ \Amer1tm1.1Nbar/Y \Tg(Prrx1-cre)1Cjt/0
involves: 129 * C57BL/6 * SJL
|
normal
skeleton phenotype |
J:173242
|
\Ctnnb1tm2Kem/\Ctnnb1+ \Ppargtm1.1(tTA)Jmgr/\Pparg+ \Tg(tetO-cre)1Jaw/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal osteoclast physiology |
J:178340
|
abnormal trabecular bone morphology |
J:178340
|
decreased bone trabecula number |
J:178340
|
decreased trabecular bone mass |
J:178340
|
decreased trabecular bone thickness |
J:178340
|
decreased trabecular bone volume |
J:178340
|
increased bone resorption |
J:178340
|
increased osteoclast cell number |
J:178340
|
osteoporosis |
J:178340
|
normal
skeleton phenotype |
J:178340
|
\Ctnnb1tm2Kem/\Ctnnb1tm2.1Kem \Corintm2(cre)Bamo/\Corin+ \Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
involves: 129S1/Sv * 129X1/SvJ * FVB/N
|
abnormal auchene hair morphology |
J:160311
|
abnormal awl hair morphology |
J:160311
|
abnormal hair cycle anagen phase |
J:160311
|
abnormal hair cycle catagen phase |
J:160311
|
abnormal hair cycle telogen phase |
J:160311
|
abnormal hair follicle physiology |
J:160311
|
abnormal hair shaft morphology |
J:160311
|
abnormal zigzag hair morphology |
J:160311
|
decreased guard hair length |
J:160311
|
delayed hair regrowth |
J:160311
|
increased hair follicle apoptosis |
J:160311
|
\Ctnnb1tm2Kem/\Ctnnb1tm2.1Kem \Gt(ROSA)26Sortm1(Ctnnb1)Kem/\Gt(ROSA)26Sor+ \Tg(Zp3-cre)93Knw/0
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6J
|
abnormal embryonic tissue morphology |
J:187739
|
abnormal germ layer development |
J:187739
|
failure to gastrulate |
J:187739
|
prenatal lethality, complete penetrance |
J:187739
|
\Ctnnb1tm2Kem/\Ctnnb1tm2.1Kem \Gt(ROSA)26Sortm1(Ctnnb1)Kem/\Gt(ROSA)26Sor+ \H2az2Tg(Wnt1-cre)11Rth/\H2az2+
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6J * CBA/J
|
abnormal brain morphology |
J:187739
|
abnormal craniofacial morphology |
J:187739
|
prenatal lethality, complete penetrance |
J:187739
|
\Ctnnb1tm2Kem/\Ctnnb1tm2.1Kem \Gt(ROSA)26Sortm1(Ctnnb1)Kem/\Gt(ROSA)26Sor+ \Tg(Foxn1-cre)1Tbo/0
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6
|
decreased body size |
J:187739
|
focal hair loss |
J:187739
|
normal
integument phenotype |
J:187739
|
\Ctnnb1tm2Kem/\Ctnnb1tm2.1Kem \Gt(ROSA)26Sortm1(Ctnnb1)Kem/\Gt(ROSA)26Sor+ \Tg(Cdx1-cre)23Kem/0
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB
|
caudal body truncation |
J:187739
|
prenatal lethality, complete penetrance |
J:187739
|
truncated tail bud |
J:187739
|
\Ctnnb1tm2Kem/\Ctnnb1tm2.1Kem \Gt(ROSA)26Sortm1(Ctnnb1)Kem/\Gt(ROSA)26Sortm1(Ctnnb1)Kem \H2az2Tg(Wnt1-cre)11Rth/\H2az2+
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6J * CBA/J
|
neonatal lethality, complete penetrance |
J:187739
|
\Ctnnb1tm2Kem/\Ctnnb1tm2.1Kem \Gt(ROSA)26Sortm1(Ctnnb1)Kem/\Gt(ROSA)26Sortm1(Ctnnb1)Kem \Tg(Cdx1-cre)23Kem/0
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB
|
abnormal digit morphology |
J:187739
|
abnormal hindlimb morphology |
J:187739
|
abnormal neural tube morphology |
J:187739
|
abnormal rib morphology |
J:187739
|
abnormal sex gland morphology |
J:187739
|
abnormal vertebrae morphology |
J:187739
|
absent hindlimb |
J:187739
|
absent tail |
J:187739
|
brachydactyly |
J:187739
|
normal
embryo phenotype |
J:187739
|
fused phalanges |
J:187739
|
open neural tube |
J:187739
|
perinatal lethality, complete penetrance |
J:187739
|
persistent cloaca |
J:187739
|
rib fusion |
J:187739
|
short ribs |
J:187739
|
small adrenal glands |
J:187739
|
small kidney |
J:187739
|
small vertebrae |
J:187739
|
vertebral fusion |
J:187739
|
\Ctnnb1tm2Kem/\Ctnnb1tm2.1Kem \Gt(ROSA)26Sortm1(Ctnnb1)Kem/\Gt(ROSA)26Sortm1(Ctnnb1)Kem \Tg(Foxn1-cre)1Tbo/0
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6
|
decreased body size |
J:187739
|
normal
integument phenotype |
J:187739
|
sparse hair |
J:187739
|
\Ctnnb1tm2Kem/\Ctnnb1tm2.1Kem \Gt(ROSA)26Sortm1(Ctnnb1)Kem/\Gt(ROSA)26Sortm1.1(Ctnnb1)Kem \Edil3Tg(Sox2-cre)1Amc/\Edil3+
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * CBA
|
abnormal embryonic tissue morphology |
J:187739
|
abnormal germ layer development |
J:187739
|
failure to gastrulate |
J:187739
|
prenatal lethality, complete penetrance |
J:187739
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Gt(ROSA)26Sortm1(Fgf8)Lma/\Gt(ROSA)26Sor+ \Tg(Msx2-cre)5Rem/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
|
abnormal autopod morphology |
J:223057
|
abnormal hindlimb morphology |
J:223057
|
abnormal ulna morphology |
J:223057
|
normal
limbs/digits/tail phenotype |
J:223057
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Gt(ROSA)26Sortm1(Fgf8)Lma/\Gt(ROSA)26Sor+ \Shhtm1(EGFP/cre)Cjt/\Shh+
involves: 129S1/Sv * 129X1/SvJ
|
abnormal reproductive system development |
J:223057
|
abnormal tail development |
J:223057
|
normal
reproductive system phenotype |
J:223057
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sor+ \H2az2Tg(Wnt1-cre)11Rth/\H2az2+
involves: 129 * C57BL/6 * CBA/J
|
absent hindbrain |
J:178971
|
absent mandible |
J:178971
|
absent maxilla |
J:178971
|
absent midbrain |
J:178971
|
absent midbrain-hindbrain boundary |
J:178971
|
small pharyngeal arch |
J:178971
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Juptm1Ruiz/\Juptm1.1Tmj \Olig2tm1(cre)Tmj/\Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
abnormal dendrite morphology |
J:178688
|
lethality throughout fetal growth and development, complete penetrance |
J:178688
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Juptm1Ruiz/\Juptm1Ruiz \Olig2tm1(cre)Tmj/\Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
abnormal neuronal migration |
J:178688
|
abnormal spinal cord lateral motor column morphology |
J:178688
|
abnormal spinal cord medial motor column morphology |
J:178688
|
abnormal spinal cord motor column morphology |
J:178688
|
abnormal ventral interneuron 1 morphology |
J:178688
|
abnormal ventral interneuron 2 morphology |
J:178688
|
decreased motor neuron number |
J:178688
|
embryonic lethality during organogenesis, complete penetrance |
J:178688
|
normal
nervous system phenotype |
J:178688
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Ppargtm1.1(tTA)Jmgr/\Pparg+ \Tg(tetO-cre)1Jaw/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal osteoclast physiology |
J:178340
|
abnormal trabecular bone morphology |
J:178340
|
decreased bone resorption |
J:178340
|
decreased osteoclast cell number |
J:178340
|
extramedullary hematopoiesis |
J:178340
|
increased bone trabecula number |
J:178340
|
increased bone volume |
J:178340
|
increased compact bone volume |
J:178340
|
increased trabecular bone thickness |
J:178340
|
increased trabecular bone volume |
J:178340
|
osteopetrosis |
J:178340
|
normal
skeleton phenotype |
J:178340
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Ppargtm1.1(tTA)Jmgr/\Pparg+ \Tg(tetO-cre)1Jaw/0 \Tg(tetO-HIST1H2BJ/GFP)47Efu/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1
|
abnormal osteoclast differentiation |
J:178340
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Ptentm1Hwu/\Ptentm1Hwu \Tg(Cdh5-cre)7Mlia/0
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c * C57BL/6 * FVB/N
|
embryonic lethality, complete penetrance |
J:135172
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Rac1tm1Djk/\Rac1+ \Tg(Msx2-cre)5Rem/0
involves: 129S4/SvJae
|
abnormal forelimb morphology |
J:145305
|
absent hindlimb |
J:145305
|
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem \Tg(KRT14-rtTA)F42Efu/0 \Tg(tetO-EDN1,-lacZ)9Mhus/0 \Tg(Tyr-cre/ERT2)13Bos/0
involves: C57BL/6J * FVB
|
abnormal coat/hair pigmentation |
J:231435
|
abnormal epidermal melanocyte morphology |
J:231435
|
abnormal melanocyte differentiation |
J:231435
|
abnormal melanocyte proliferation |
J:231435
|
\Ctnnb1tm2Kem/\Ctnnb1tm3Kba \Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sor+ \H2az2Tg(Wnt1-cre)11Rth/\H2az2+
involves: 129 * C57BL/6 * CBA/J
|
abnormal cerebellum development |
J:178971
|
abnormal craniofacial bone morphology |
J:178971
|
absent midbrain-hindbrain boundary |
J:178971
|